Format
Sort by
Items per page

Send to

Choose Destination

Best matches for zofran hyperemesis gravidarum:

Search results

Items: 1 to 20 of 41

1.

Ondansetron in Pregnancy and the Risk of Congenital Malformations: A Systematic Review.

Lavecchia M, Chari R, Campbell S, Ross S.

J Obstet Gynaecol Can. 2018 Jul;40(7):910-918. doi: 10.1016/j.jogc.2017.10.024. Epub 2018 May 10.

PMID:
29754832
2.

Safety considerations surrounding use of treatment options for nausea and vomiting in pregnancy.

Koren G.

Expert Opin Drug Saf. 2017 Nov;16(11):1227-1234. doi: 10.1080/14740338.2017.1361403. Epub 2017 Aug 9. Review.

PMID:
28749713
3.

Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis.

Boelig RC, Barton SJ, Saccone G, Kelly AJ, Edwards SJ, Berghella V.

J Matern Fetal Neonatal Med. 2018 Sep;31(18):2492-2505. doi: 10.1080/14767058.2017.1342805. Epub 2017 Jul 11.

PMID:
28614956
4.

Treatment options for hyperemesis gravidarum.

Abramowitz A, Miller ES, Wisner KL.

Arch Womens Ment Health. 2017 Jun;20(3):363-372. doi: 10.1007/s00737-016-0707-4. Epub 2017 Jan 9. Review.

PMID:
28070660
5.

Publishing negative findings and the challenge of avoiding type II errors in studies of suspect teratogens: Example of a recent ondansetron publication.

Edlavitch SA.

Reprod Toxicol. 2017 Jan;67:125-128. doi: 10.1016/j.reprotox.2016.12.001. Epub 2016 Dec 15. Review.

PMID:
27988282
6.

Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment.

O'Donnell A, McParlin C, Robson SC, Beyer F, Moloney E, Bryant A, Bradley J, Muirhead C, Nelson-Piercy C, Newbury-Birch D, Norman J, Simpson E, Swallow B, Yates L, Vale L.

Health Technol Assess. 2016 Oct;20(74):1-268. Review.

7.

Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy: A Systematic Review.

McParlin C, O'Donnell A, Robson SC, Beyer F, Moloney E, Bryant A, Bradley J, Muirhead CR, Nelson-Piercy C, Newbury-Birch D, Norman J, Shaw C, Simpson E, Swallow B, Yates L, Vale L.

JAMA. 2016 Oct 4;316(13):1392-1401. doi: 10.1001/jama.2016.14337. Review.

PMID:
27701665
8.

Ondansetron and pregnancy: Understanding the data.

Kennedy D.

Obstet Med. 2016 Mar;9(1):28-33. doi: 10.1177/1753495X15621154. Epub 2015 Dec 23. Review.

9.

Ondansetron Use in Pregnancy andOndansetron Use in Pregnancy and Birth Defects: A Systematic Review.

Reichmann JP, Kirkbride MS.

Obstet Gynecol. 2016 Aug;128(2):409. doi: 10.1097/AOG.0000000000001548. No abstract available.

PMID:
27454720
10.

Interventions for treating hyperemesis gravidarum.

Boelig RC, Barton SJ, Saccone G, Kelly AJ, Edwards SJ, Berghella V.

Cochrane Database Syst Rev. 2016 May 11;(5):CD010607. doi: 10.1002/14651858.CD010607.pub2. Review.

PMID:
27168518
11.

Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States.

Fejzo MS, MacGibbon KW, Mullin PM.

Reprod Toxicol. 2016 Jul;62:87-91. doi: 10.1016/j.reprotox.2016.04.027. Epub 2016 May 2.

PMID:
27151373
12.

Ondansetron Use in Pregnancy and Birth Defects: A Systematic Review.

Carstairs SD.

Obstet Gynecol. 2016 May;127(5):878-83. doi: 10.1097/AOG.0000000000001388. Review.

PMID:
27054939
13.

Ondansetron Use in Pregnancy.

Siminerio LL, Bodnar LM, Venkataramanan R, Caritis SN.

Obstet Gynecol. 2016 May;127(5):873-7. doi: 10.1097/AOG.0000000000001375.

PMID:
27054931
14.

Fluctuating serum aspartate aminotransferase activity in a complicated pregnancy.

Mills JR, Greene DN, Bainton J, Lorey TS, Baumann NA.

Clin Chem. 2015 Oct;61(10):1241-4. doi: 10.1373/clinchem.2014.228247. No abstract available.

15.

Intestinal obstruction is a rare complication of ondansetron exposure in hyperemesis gravidarum.

Fejzo MS, MacGibbon K, Mullin P.

Reprod Toxicol. 2015 Nov;57:207. doi: 10.1016/j.reprotox.2015.07.071. Epub 2015 Jul 18. No abstract available.

PMID:
26196894
16.

Practical selection of antiemetics in the ambulatory setting.

Flake ZA, Linn BS, Hornecker JR.

Am Fam Physician. 2015 Mar 1;91(5):293-6.

17.

Intestinal obstruction in pregnancy by ondansetron.

Cohen R, Shlomo M, Dil DN, Dinavitser N, Berkovitch M, Koren G.

Reprod Toxicol. 2014 Dec;50:152-3. doi: 10.1016/j.reprotox.2014.10.014. Epub 2014 Oct 24.

PMID:
25461913
18.

The outpatient management and special considerations of nausea and vomiting in pregnancy.

Clark SM, Dutta E, Hankins GD.

Semin Perinatol. 2014 Dec;38(8):496-502. doi: 10.1053/j.semperi.2014.08.014. Epub 2014 Sep 27. Review.

PMID:
25267280
19.

Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial.

Oliveira LG, Capp SM, You WB, Riffenburgh RH, Carstairs SD.

Obstet Gynecol. 2014 Oct;124(4):735-42. doi: 10.1097/AOG.0000000000000479.

PMID:
25198265
20.

Management of gastrointestinal complaints in differentiated thyroid cancer patients treated with (131)I: comparison of the efficacy of pantoprazole, metoclopramide, and ondansetron - a randomized clinical trial.

Mirzababaee M, Shafiei B, Seifollahi S, Motazdian M, Fatholahi L, Delavari S, Naghshine R, Baharfar N, Tabeie F, Javadi H, Assadi M, Asli IN.

Nuklearmedizin. 2014;53(5):186-9. doi: 10.3413/Nukmed-0654-14-03. Epub 2014 Jun 25.

PMID:
24961816

Supplemental Content

Loading ...
Support Center